Clinical Trial News and Research

RSS

Alimta approved as first treatment for Mesothelioma, a deadly cancer caused by asbestos

Lilly UK announced today that Alimta( (pemetrexed) will be available shortly for the treatment of people diagnosed with mesothelioma, a cancer of the lining of the lungs for which there is no known cure. Pemetrexed is the first licenced treatment for malignant pleural mesothelioma, in combination with cisplatin.

1 Nov 2004

Brief psychological interventions are effective in relieving traumatic stress symptoms in family members

Family therapy and other psychological treatments may help reduce symptoms of post-traumatic stress among teenaged survivors of childhood cancer--as well as among their parents.

28 Oct 2004

Ruboxistaurin may reduce vision loss from diabetes-induced eye disease

Eli Lilly and Company's investigational compound ruboxistaurin may reduce vision loss from diabetes-induced eye disease, according to new analyses of previously reported data presented at the 2004 Joint Meeting of the American Academy of Ophthalmology and the European Society of Ophthalmology in New Orleans, La.

26 Oct 2004

Researchers are comparing two drugs used to treat pediatric bipolar disorder

University of Illinois at Chicago researchers are comparing two drugs used to treat pediatric bipolar disorder patients to evaluate how the drugs affect brain function in children with the disorder.

25 Oct 2004

Why some anesthesiologists end up abusing drugs

University of Florida researchers have presented a new theory at the 34th annual Society for Neuroscience on why some anesthesiologists end up abusing drugs.

25 Oct 2004

MedImmune initiates clinical trial comparing intranasal influenza vaccine with injectable flu vaccine

MedImmune announced that it has initiated a pivotal head-to-head Phase 3 clinical trial designed to compare its next-generation, refrigerator- stable intranasal influenza vaccine (CAIV-T: cold adapted intranasal influenza vaccine, trivalent) with the injectable flu shot (TIV: trivalent influenza vaccine).

22 Oct 2004

New antibody to prevent respiratory syncytial virus in premature babies

Virginia Commonwealth University researchers are studying the effectiveness of introducing a new antibody in premature infants to manage the most common form of lower respiratory tract infections in children worldwide.

21 Oct 2004

Insulin pumps effective for children with diabetes

Pre-school youngsters with type I diabetes can be treated as successfully with insulin pumps as with daily injections, researchers at the Indiana University School of Medicine report.

18 Oct 2004

Pfizer provides information about its COX-2 product Bextra (valdecoxib)

In view of the increased focus on alternative treatment options for people with arthritis, Pfizer is providing information to healthcare professionals about its COX-2 product Bextra® (valdecoxib).

18 Oct 2004

Low dose aspirin dosages trigger the body to generate its own anti-inflammatory compounds

Researchers at Brigham and Women’s Hospital (BWH) and colleagues have demonstrated for the first time in humans in a randomized clinical trial that low-dose aspirin - dosages equivalent to one baby aspirin (81 mg) - trigger the body to generate its own anti-inflammatory compounds that help fight unwanted inflammation.

13 Oct 2004

Researchers stimulate the body to repair tissue damaged by peripheral arterial obstructive disease

Duke University Medical Center researchers have shown that they can stimulate the body to produce its own naturally occurring growth factors to promote blood vessel growth into tissue damaged by peripheral arterial obstructive disease (PAOD).

13 Oct 2004

Researchers identify common mutation in T-cell acute lymphocytic leukemia

Researchers at Brigham and Women’s Hospital (BWH) and Dana-Farber Cancer Institute (DFCI) have made a breakthrough discovery, identifying a common mutation in T-cell acute lymphocytic leukemia (T-ALL), an important form of cancer in children and adolescents.

11 Oct 2004

Pilot study of mind-to-movement device shows early promise

In March 2002, Brown University researchers published an astounding piece of science. Three rhesus monkeys, they reported, could control a computer cursor without their hands. They used their minds instead.

10 Oct 2004

Breast cancer drug Taxotere extends life of prostate cancer patients

Men with androgen-independent (hormone-refractory) metastatic prostate cancer treated with the breast-cancer drug Taxotere (docetaxel) Injection Concentrate in combination with the drug estramustine survived 20 percent longer than similar patients receiving the standard therapy

6 Oct 2004

EMEA statement following withdrawal of Vioxx (rofecoxib)

EU regulators met with the marketing authorisation holder of Vioxx (rofecoxib), Merck Sharp & Dohme, on 4-5 October 2004 at the informal meeting of the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) held in Scheveningen, The Netherlands.

6 Oct 2004

Clinical Trial News and Research

Alimta approved as first treatment for Mesothelioma, a deadly cancer caused by asbestos

Brief psychological interventions are effective in relieving traumatic stress symptoms in family members

Ruboxistaurin may reduce vision loss from diabetes-induced eye disease

Researchers are comparing two drugs used to treat pediatric bipolar disorder

Why some anesthesiologists end up abusing drugs

MedImmune initiates clinical trial comparing intranasal influenza vaccine with injectable flu vaccine

New antibody to prevent respiratory syncytial virus in premature babies

Insulin pumps effective for children with diabetes

Pfizer provides information about its COX-2 product Bextra (valdecoxib)

Low dose aspirin dosages trigger the body to generate its own anti-inflammatory compounds

Researchers stimulate the body to repair tissue damaged by peripheral arterial obstructive disease

Researchers identify common mutation in T-cell acute lymphocytic leukemia

Pilot study of mind-to-movement device shows early promise

Breast cancer drug Taxotere extends life of prostate cancer patients

EMEA statement following withdrawal of Vioxx (rofecoxib)

Women who take the hormone therapy estrogen plus progestin have double the risk for venous thrombosis

Researchers grow mouth lining into pieces of bio-bandage

Moderate exercise in mice after they were infected with influenza protects them from dying

People with asthma can drink milk too!

Prognostic factors influencing survival in patients with brain metastases identified

Sensing a Healthier Future

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Latest Life Science News